Andrew ElBardissi
InvestorPartner at Deerfield Management Company
New York, New York
Writes $10M – $50M checks · typically $25M
About
A partner on Deerfield's Medical Technologies team who joined in 2017, previously a principal at Longitude Capital investing in medtech and biotech and an associate in JPMorgan's healthcare investment banking practice. He is a trained surgeon with an M.D. from the Mayo Clinic, an M.P.H. and M.B.A. from Harvard, and residency training at Harvard's Brigham and Women's Hospital and Stanford.
Experience
- Deerfield ManagementPartnercurrent2017 — presentNew York, New York, United States
- Medical Microinstruments, Inc.Board Membercurrent2022 — present
- Aurion BiotechBoard Membercurrent2022 — present
- BitterootBoard Membercurrent2021 — present
- Adela BioBoard Membercurrent2021 — present
- Encodia, Inc.Board Membercurrent2020 — present
- Endologix LLCBoard Membercurrent2020 — present
- Sema4Board Membercurrent2020 — present
- Reprieve CardiovascularBoard Membercurrent2020 — present
- Element Science, Inc.Board Membercurrent2019 — present
- Singular GenomicsBoard Membercurrent2018 — present
- Axon Therapies Inc.Board Membercurrent2018 — present
- InCarda TherapeuticsBoard Membercurrent2018 — present
- CathWorksBoard Membercurrent2018 — present
- Epic Sciences │ The Power of ClarityBoard Membercurrent2017 — present
- Sollis TherapeuticsBoard Membercurrent2017 — present
- Acutus Medical, Inc.Board Membercurrent2017 — present
- FARAPULSE, Inc.Board Membercurrent2017 — present
- V-WaveBoard Membercurrent2017 — present
- Conventus-Flower OrthopedicsBoard Membercurrent2017 — present
Education
- Harvard Business SchoolMBA, Business
- Harvard T.H. Chan School of Public HealthMPH, Quantitative Methods
- Mayo Clinic Alix School of MedicineDoctor of Medicine (M.D.), Medicine
Skills & more
+12 more
Market ResearchCompetitive AnalysisDue DiligenceFinancial AnalysisVenture CapitalInvestmentsMedical DevicesInvestment BankingClinical ResearchMergers & AcquisitionsStart-upsPrivate EquityFrom Andrew's professional profile.
Same school
Also attended Harvard Business School1,777
+ 1,771 more
Also attended Harvard T.H. Chan School of Public Health28
+ 22 more
Shared employers
Also worked at Medical Microinstruments, Inc.1
Also worked at Encodia, Inc.1
Also worked at Sema41
Deals · 12
AdelaBoard seat
via Deerfield Management Company · filed Jul 2025 · $27M raise
Medical Microinstruments, Inc.Board seat
via Deerfield Management Company · filed Mar 2024 · $110M raise
NeochordBoard seat
via Deerfield Management Company · filed Nov 2022 · $6M raise
Acutus MedicalBoard seat
via Deerfield Management Company · filed Jul 2022 · $4.2M raise
Reprieve CardiovascularBoard seat
via Deerfield Management Company · filed Jun 2022 · $15M raise
Aurion BiotechBoard seat
via Deerfield Management Company · filed Apr 2022 · $26.1M raise
NXT BiomedicalBoard seat
via Deerfield Management Company · filed May 2021 · $10M raise
InCarda TherapeuticsBoard seat
via Deerfield Management Company · filed Oct 2020 · $50M raise
Element ScienceBoard seat
via Deerfield Management Company · filed Mar 2020 · $145.6M raise
Axon TherapiesBoard seat
via Deerfield Management Company · filed Feb 2019 · $15M raise
Conventus OrthopaedicsBoard seat
via Deerfield Management Company · filed Jan 2019 · $5M raise
Iowa ApproachBoard seat
via Deerfield Management Company · filed Aug 2018 · $12M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Deerfield Management Company
Network13
▶1 more connections
Investors connected to Andrew in public investor directories — a warm-intro map.
























